Phase I dose finding studies of obatoclax (GX15-070), a small molecule Pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma

Jimmy J. Hwang, John Kuruvilla, David Mendelson, Michael J. Pishvaian, J. F. Deeken, Lillian L. Siu, Mark S. Berger, Jean Viallet, John L. Marshall

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I dose finding studies of obatoclax (GX15-070), a small molecule Pan-BCL-2 family antagonist, in patients with advanced solid tumors or lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences